Target (CBDY) Long-Term Deferred Tax (2020 - 2024)
Target (CBDY) reported Long-Term Deferred Tax of $5.4 million for Q4 2024, up 7.6% quarter-over-quarter from $5.0 million in Q4 2022.
Target (CBDY) Long-Term Deferred Tax (2020 - 2024) Analysis & Trends
Target (CBDY) has 3 years of Long-Term Deferred Tax data on file, last reported at $5.4 million in Q4 2024.
- Long-Term Deferred Tax for Q4 2024 came in at $5.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $5.4 million (changed N/A YoY), and the FY2024 annual result was $5.4 million, changed N/A from the prior year.
- Long-Term Deferred Tax climbed to $5.4 million in Q4 2024 per CBDY's latest filing, from $5.0 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $5.4 million in Q4 2024 and troughed at $3.5 million in Q4 2020.
- A 3-year average of $4.6 million and a median of $5.0 million in 2022 frame the typical range for Long-Term Deferred Tax.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Target | - | - | 191,787.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.40 Mn |
| Dec 31, 2022 | 5.02 Mn |
| Dec 31, 2020 | 3.50 Mn |